How to use Technology Offers

Product name

Detection of TSE-induced modifications

Summary

A tool for ante-mortem diagnosis of TSE-induced changes.

Organization name

ipal GmbH

Profile

Samples of body tissue or body fluid are examined by infrared (IR) spectroscopy. The IR spectra of the sample are compared with a reference data bank consisting of IR spectra obtained from healthy material or from pathologically changed tissue samples. Evaluation is carried out using pattern recognition techniques. The technology may be beneficial not only for veterinarian but also clinical use.

Advantages

  • Prototype of test system was developed & proof of principle was demonstrated in two independent BSE tests using serum from cattle: excellent basis for successful product development
  • Modules of the test system consist of established hard- and software: further facilitation of product development
  • Samples from body tissue & body fluids can be tested: easy-to-handle ante-mortem, facultatively non-invasive diagnostic test for TSE
  • Test system is applicable in a veterinary as well as in a clinical setting

International patents have been filed and already granted to a greater extent.

The technology was developed at the Robert-Koch-Institute (Berlin/Germany) and is offered by IPAL.

IPAL GmbH 
Dr. Christian Wunsch 
Project Manager
christian.wunsch(at)ipal.de 

About IPAL 

The ipal GmbH patent agency assesses and markets the inventions of scientists in the area of Life Sciences and Physics & Engineering from Charité-Universitätsmedizin (University Medicine), Robert Koch Institute, Deutsches Herzzentrum (German Heart Institute), Bundesanstalt für Materialprüfung (BAM - Federal Institute for Materials Research and Testing), the Zuse Institute as well as the Paul Ehrlich Institute, Langen and the Jacobs University Bremen. IPAL provides all of the services necessary - from the assessment of patentable technologies to a comprehensive patent protection all the way to the evaluation of sales returns potentials on the market and successful commercialisation through the use of licensing agreements.


Description File

 04115_TSE.pdf

URL

http://www.ipal.de/en/technology_offers/life_sciences/


Your feedback

back

Search


Sector
Technology
Development Stage
Disease Category
Organ

latest entries